Global Rapid Plasma Reagin Test Market Report 2022: Industry Set to Grow by $46.2 Million by 2026, at an Annual Rate of 4.26% -

The "Global Rapid Plasma Reagin Test Market 2022-2026" report has been added to's offering.

The publisher has been monitoring the rapid plasma reagin test market and it is poised to grow by $ 46.28 mn during 2022-2026 progressing at a CAGR of 4.26% during the forecast period.

The market is driven by the increasing incidence of syphilis, the adoption of serological tests by blood banks, the automated RPR systems, and the rising uptake of RPR in antenatal clinics (ANCs).

Additionally, the growing number of healthcare testing programs and awareness programs for sexually transmitted diseases, and technological advancements in RPR testing will lead to sizable demand in the market.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

Key Topics Covered:

1 Executive Summary

1.1 Market overview

2 Market Landscape

2.1 Market ecosystem

3 Market Sizing

3.1 Market definition

3.2 Market segment analysis

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026

4 Five Forces Analysis

5 Market Segmentation by Test

5.1 Market segments

5.2 Comparison by Test

5.3 Rapid plasma reagin test kits - Market size and forecast 2021-2026

5.4 Analyzers and instruments - Market size and forecast 2021-2026

5.5 Reagents - Market size and forecast 2021-2026

5.6 Market opportunity by Test

6 Customer Landscape

6.1 Customer landscape overview

7 Geographic Landscape

8 Drivers, Challenges, and Trends

8.1 Market drivers

8.2 Market challenges

8.3 Impact of drivers and challenges

8.4 Market trends

9 Vendor Landscape

9.1 Overview

9.2 Vendor landscape

9.3 Landscape disruption

9.4 Industry risks

Companies Mentioned

  • Abbott Laboratories
  • Anamol Laboratories Pvt. Ltd.
  • ARKRAY Inc.
  • Arlington Scientific Inc.
  • Atlas Medical GmbH
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • Cardinal Health Inc.
  • F. Hoffmann La Roche Ltd.
  • Innovatek Medical Inc.
  • Lorne Laboratories Ltd.
  • Mediclone Biotech
  • Newmarket Biomedical Ltd.
  • Novacyt SA
  • Sclavo Diagnostics International S.r.l.
  • Sekisui Chemical Co. Ltd.
  • Thermo Fisher Scientific Inc.

For more information about this report visit


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.